Antagonist antibody to NPR1, REGN-NPR17544 (baloncibart), increases blood pressure and plasma volume
Authors:
Preprint
- 18 November 2026
- preprint
- Published by Springer Nature in Research Square
Abstract
Hypotension and hypovolemia cause morbidity across many clinical disorders, yet pharmacologic options are limited. REGN-NPR1 7544 (REGN7544/baloncibart), a first-in-class monoclonal antibody, allosterically antagonizes natriuretic peptide receptor 1 (NPR1), a membrane guanylyl cyclase activated by atrial natriuretic peptide (ANP) and brain natriuretic peptide to promote vasorelaxation and natriuresis. REGN-NPR1 7544 bound human and cynomolgus monkey NPR1 with nanomolar affinity, increased systolic blood pressure (SBP) in NPR1 Hu/Hu mice by 10–15 mmHg for up to 28 days, corrected severe hypotension in ANP-overexpressing mice, and inhibited ANP-induced mesenteric vessel relaxation. In monkeys, SBP increased by 15–20 mmHg, with biomarkers consistent with plasma volume expansion. In a randomized, placebo-controlled, phase 1 single-ascending-dose study in healthy adults (N = 80), doses ≥ 100 mg were generally well-tolerated, producing sustained 5–10 mmHg SBP increases and biomarker signals consistent with volume expansion. These data implicate tonic NPR1 signaling in human blood pressure and volume regulation, supporting REGN-NPR1 7544 as a candidate for hypotension and hypovolemia.All Related Versions
This publication has 32 references indexed in Scilit:
- Blood volume deficit in postural orthostatic tachycardia syndrome assessed by semiautomated carbon monoxide rebreathingClinical Autonomic Research, 2024
- Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1Autonomic Neuroscience, 2021
- Natriuretic Peptides and Normal Body Fluid RegulationComprehensive Physiology, 2018
- Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait lociNature Genetics, 2016
- N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective studyJournal of Critical Care, 2015
- F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analysesNature Biotechnology, 2006
- Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase‐A gene by αMHC‐Cre‐mediated recombinationGenesis, 2004
- High-throughput engineering of the mouse genome coupled with high-resolution expression analysisNature Biotechnology, 2003
- Atrial natriuretic peptide response to postural change and medication in familial dysautonomiaClinical Autonomic Research, 1994
- Elevated atrial natriuretic factor in the plasma: cause or effect in “idiopathic orthostatic hypotension”?International Journal of Cardiology, 1990